| JNK Inhibitor VIII |
ENSG00000104691.10 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000118412.8 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000124835.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK Inhibitor VIII |
ENSG00000131484.3 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000131484.3 |
Predicted lncRNA |
Sarcoma |
|
| JNK Inhibitor VIII |
ENSG00000132204.9 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000142396.6 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000146666.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000152487.6 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK Inhibitor VIII |
ENSG00000153363.8 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000157306.10 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000163597.10 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000163597.10 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000164621.5 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000167912.5 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000170590.4 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000172250.10 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000172250.10 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000172965.10 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000172965.10 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000174171.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000174171.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000174365.15 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000175061.13 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000175061.13 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000175701.6 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000175873.3 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000177337.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000177406.4 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000177406.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000177410.8 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000177410.8 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000177738.3 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000177788.5 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000177993.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000177993.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000178193.5 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000178248.10 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000179219.5 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000179406.6 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000179523.4 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000179818.9 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000179818.9 |
Predicted lncRNA |
Sarcoma |
|
| JNK Inhibitor VIII |
ENSG00000179859.7 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000180846.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK Inhibitor VIII |
ENSG00000181097.5 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000181097.5 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000182021.5 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000183674.7 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000184274.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000184856.6 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000185186.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000185186.4 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000185837.3 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000188206.5 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000188206.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000188365.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000188660.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000189223.9 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000189223.9 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000189229.10 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000189419.5 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK Inhibitor VIII |
ENSG00000196553.9 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000196559.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000196696.8 |
Predicted lncRNA |
Sarcoma |
|
| JNK Inhibitor VIII |
ENSG00000196756.7 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000196951.6 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000197210.7 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000197210.7 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000197813.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000197989.9 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000198106.7 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000203288.3 |
Predicted lncRNA |
Sarcoma |
|
| JNK Inhibitor VIII |
ENSG00000203441.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000203441.2 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000203496.4 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000203497.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000203497.2 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000203499.6 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000203865.5 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000203875.6 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000204055.4 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000204055.4 |
Predicted lncRNA |
Sarcoma |
|
| JNK Inhibitor VIII |
ENSG00000204272.6 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000204528.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000204625.6 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000204685.5 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000204791.4 |
Predicted lncRNA |
Sarcoma |
|
| JNK Inhibitor VIII |
ENSG00000204802.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000204837.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000204837.2 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000204934.6 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000204934.6 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000205041.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000205041.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000205054.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000205266.5 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000205537.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000205559.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK Inhibitor VIII |
ENSG00000205662.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000205662.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000205663.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000205663.5 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000206176.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000206176.5 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000206417.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK Inhibitor VIII |
ENSG00000206417.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000212694.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000212766.5 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000212766.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000212978.5 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000213742.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000213742.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000213904.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000213963.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000213994.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000214293.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000214432.5 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000214432.5 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000214546.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000214650.2 |
Predicted lncRNA |
Sarcoma |
|
| JNK Inhibitor VIII |
ENSG00000214725.3 |
Predicted lncRNA |
Sarcoma |
|
| JNK Inhibitor VIII |
ENSG00000214770.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000214770.2 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000214772.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000214783.5 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000214803.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000214922.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000214955.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000215023.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000215039.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000215159.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000215241.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000215256.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000215417.6 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000215417.6 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000215424.5 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000215458.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000215692.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000215769.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000215808.2 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000215841.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000215859.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000217576.7 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000218510.3 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000221571.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000221817.5 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000221817.5 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000222041.6 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000222043.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000223393.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000223396.2 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000223414.2 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000223473.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000223475.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000223477.3 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000223482.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000223485.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000223485.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000223525.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000223546.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000223546.2 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000223561.2 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000223579.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000223598.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK Inhibitor VIII |
ENSG00000223692.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000223725.2 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000223734.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000223734.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000223749.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000223749.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000223779.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000223791.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000223797.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000223804.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000223813.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000223823.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK Inhibitor VIII |
ENSG00000223839.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000223842.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000223884.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000223884.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000223960.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000224020.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000224032.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000224032.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000224034.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000224093.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK Inhibitor VIII |
ENSG00000224142.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000224209.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000224238.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000224271.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000224292.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000224292.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000224356.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000224384.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK Inhibitor VIII |
ENSG00000224394.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000224429.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000224429.3 |
Predicted lncRNA |
Sarcoma |
|
| JNK Inhibitor VIII |
ENSG00000224468.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000224468.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000224490.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000224536.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000224541.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000224609.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000224621.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000224621.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000224635.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000224660.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000224687.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000224698.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK Inhibitor VIII |
ENSG00000224699.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000224707.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000224818.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000224818.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000224863.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK Inhibitor VIII |
ENSG00000224884.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000224914.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000224934.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000224945.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000224959.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000224969.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000224969.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000224973.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000224975.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000224985.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK Inhibitor VIII |
ENSG00000224992.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000225030.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000225032.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000225057.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000225138.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000225173.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000225173.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000225177.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000225195.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000225205.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000225205.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000225205.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000225213.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000225218.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000225218.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000225234.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000225235.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK Inhibitor VIII |
ENSG00000225278.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000225284.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000225311.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000225331.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000225331.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000225331.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000225335.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000225393.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000225434.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000225439.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000225442.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000225470.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000225484.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000225484.2 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000225489.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000225506.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000225506.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000225518.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000225518.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000225528.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000225548.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000225602.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000225611.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000225620.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000225655.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK Inhibitor VIII |
ENSG00000225721.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000225733.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000225733.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000225744.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000225745.4 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000225745.4 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000225761.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK Inhibitor VIII |
ENSG00000225761.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000225778.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000225793.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000225793.2 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000225806.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000225973.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000225973.3 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000226009.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000226029.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000226088.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000226088.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK Inhibitor VIII |
ENSG00000226088.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000226101.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000226194.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000226237.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000226281.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000226291.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000226328.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000226328.2 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000226352.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000226352.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000226377.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000226380.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000226381.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000226381.3 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000226386.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000226386.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000226438.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000226453.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000226505.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK Inhibitor VIII |
ENSG00000226508.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000226526.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000226598.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000226637.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000226648.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000226669.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000226688.2 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000226699.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000226746.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000226824.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000226853.2 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000226864.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK Inhibitor VIII |
ENSG00000226889.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000226900.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000226920.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000226950.2 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000226953.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000227005.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000227014.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000227039.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000227045.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000227076.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000227110.2 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000227161.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000227186.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000227197.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000227200.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000227215.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000227218.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000227256.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000227285.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000227285.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000227354.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000227359.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000227359.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000227372.6 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000227375.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK Inhibitor VIII |
ENSG00000227375.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000227388.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000227398.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000227400.2 |
Predicted lncRNA |
Sarcoma |
|
| JNK Inhibitor VIII |
ENSG00000227431.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000227431.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000227486.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000227486.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000227487.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000227495.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000227496.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000227516.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000227540.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000227542.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000227542.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000227603.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000227637.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000227637.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000227640.2 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000227673.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000227695.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000227704.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000227704.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK Inhibitor VIII |
ENSG00000227704.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000227857.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000227896.2 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000227908.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000227914.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000227946.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000227946.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000227959.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000227959.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000227959.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000227963.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000228010.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000228010.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK Inhibitor VIII |
ENSG00000228037.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000228044.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000228106.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000228109.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000228126.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000228150.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000228150.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000228192.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000228203.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000228223.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000228237.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000228242.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000228251.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000228265.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000228265.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000228271.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000228274.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000228277.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000228288.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000228302.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000228317.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000228323.2 |
Predicted lncRNA |
Sarcoma |
|
| JNK Inhibitor VIII |
ENSG00000228327.2 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000228352.2 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000228353.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000228358.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000228369.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000228372.3 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000228372.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000228389.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000228395.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000228412.2 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000228452.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000228486.5 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000228540.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK Inhibitor VIII |
ENSG00000228544.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000228573.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000228634.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000228649.4 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000228692.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000228763.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000228775.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000228779.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000228801.5 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000228809.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000228812.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000228824.2 |
Predicted lncRNA |
Sarcoma |
|
| JNK Inhibitor VIII |
ENSG00000228826.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000228865.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000228889.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000228889.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000228889.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000228889.2 |
Predicted lncRNA |
Sarcoma |
|
| JNK Inhibitor VIII |
ENSG00000228906.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000228939.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000229021.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK Inhibitor VIII |
ENSG00000229021.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000229043.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK Inhibitor VIII |
ENSG00000229056.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK Inhibitor VIII |
ENSG00000229056.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000229109.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000229109.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000229122.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000229122.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000229124.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000229127.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000229152.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000229178.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000229180.4 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000229227.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000229348.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK Inhibitor VIII |
ENSG00000229368.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000229373.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000229382.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000229401.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000229498.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000229512.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000229521.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000229537.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000229539.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000229539.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000229582.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000229583.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000229589.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000229589.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000229645.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000229647.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000229688.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000229723.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000229727.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000229750.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000229780.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000229807.5 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000229862.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000229893.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000229901.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000229912.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000229950.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000229953.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000229956.5 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000230082.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000230084.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000230102.3 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000230105.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000230124.2 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000230184.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000230337.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000230366.5 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000230368.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000230424.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000230438.5 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000230439.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000230439.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000230454.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000230530.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000230555.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000230563.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000230590.3 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000230612.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000230630.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000230724.5 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000230747.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000230753.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000230825.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000230844.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000230844.2 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000230896.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000230912.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000231010.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000231010.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000231025.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000231064.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000231073.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000231073.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000231074.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000231102.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000231105.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000231125.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000231134.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000231185.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000231187.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000231187.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000231242.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000231249.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000231305.3 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000231312.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000231365.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000231407.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000231483.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000231512.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000231521.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK Inhibitor VIII |
ENSG00000231563.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000231607.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000231611.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000231651.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000231652.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK Inhibitor VIII |
ENSG00000231663.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000231705.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000231711.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000231721.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000231731.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000231764.4 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000231770.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000231770.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000231774.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000231794.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000231840.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000231851.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000231871.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000231882.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000231889.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000231889.3 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000231903.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000231944.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000231966.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000231993.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000232002.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000232019.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000232065.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000232093.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000232093.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000232098.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000232098.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000232104.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000232160.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000232224.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000232233.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000232284.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000232300.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000232300.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK Inhibitor VIII |
ENSG00000232328.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000232354.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000232354.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000232388.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000232406.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000232453.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK Inhibitor VIII |
ENSG00000232470.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000232470.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK Inhibitor VIII |
ENSG00000232485.2 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000232498.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000232519.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000232527.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000232527.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000232530.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000232533.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000232600.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000232618.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000232618.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK Inhibitor VIII |
ENSG00000232623.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000232628.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000232640.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000232686.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000232710.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000232721.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000232732.5 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000232732.5 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000232739.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK Inhibitor VIII |
ENSG00000232754.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000232828.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK Inhibitor VIII |
ENSG00000232860.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000232876.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000232893.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000232909.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000232931.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000232936.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000232940.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000232956.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000232969.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000233016.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000233017.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000233081.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000233137.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000233137.2 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000233184.2 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000233184.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000233215.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000233221.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000233223.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000233244.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000233250.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000233255.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000233293.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000233330.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000233339.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000233355.2 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000233360.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000233396.3 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000233461.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000233483.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000233496.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000233509.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000233559.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000233643.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000233654.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000233654.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000233672.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000233695.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000233723.3 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000233775.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000233776.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000233785.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000233799.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000233825.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000233845.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000233854.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000233871.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK Inhibitor VIII |
ENSG00000233885.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000233895.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000233901.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000234019.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000234062.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000234072.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000234160.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000234160.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000234171.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000234171.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000234197.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000234199.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000234215.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000234225.2 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000234264.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000234311.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000234423.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK Inhibitor VIII |
ENSG00000234432.3 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000234449.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000234456.3 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000234509.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK Inhibitor VIII |
ENSG00000234572.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000234608.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000234630.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000234678.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000234684.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000234741.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000234789.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000234789.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000234818.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000234848.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000234869.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK Inhibitor VIII |
ENSG00000234899.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000234899.5 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000234902.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000234912.5 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000235016.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000235029.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000235077.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK Inhibitor VIII |
ENSG00000235079.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000235085.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000235085.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000235091.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000235092.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000235100.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000235100.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000235117.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000235142.3 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000235159.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000235204.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000235214.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000235236.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000235257.4 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000235280.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000235296.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000235326.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000235398.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000235398.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000235408.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000235423.4 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000235426.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000235437.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000235437.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000235453.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000235477.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000235529.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK Inhibitor VIII |
ENSG00000235545.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000235609.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000235669.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK Inhibitor VIII |
ENSG00000235706.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000235772.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000235779.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000235781.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000235786.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000235790.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000235852.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000235910.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK Inhibitor VIII |
ENSG00000235910.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000235919.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000235934.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000235954.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000235958.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000236003.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000236081.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000236088.5 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000236088.5 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000236194.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK Inhibitor VIII |
ENSG00000236199.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000236199.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000236200.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000236204.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000236226.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK Inhibitor VIII |
ENSG00000236255.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK Inhibitor VIII |
ENSG00000236299.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000236305.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000236333.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000236364.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000236432.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000236434.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000236438.2 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000236438.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000236472.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000236472.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000236526.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000236558.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000236558.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000236601.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000236618.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000236618.2 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000236671.3 |
Predicted lncRNA |
Sarcoma |
|
| JNK Inhibitor VIII |
ENSG00000236682.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK Inhibitor VIII |
ENSG00000236711.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000236711.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000236751.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000236772.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000236778.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000236810.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000236830.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000236850.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000236859.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000236859.2 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000236869.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000236896.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000236896.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000236901.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000236901.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000236914.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000236924.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000236935.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000236943.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000236947.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000236953.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000237017.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000237021.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000237021.2 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000237037.5 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000237149.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000237152.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000237179.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000237250.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000237253.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000237292.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000237310.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000237310.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000237328.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000237380.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000237410.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK Inhibitor VIII |
ENSG00000237438.2 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000237523.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000237596.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK Inhibitor VIII |
ENSG00000237604.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000237605.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000237609.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000237646.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK Inhibitor VIII |
ENSG00000237664.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000237664.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000237685.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000237689.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000237697.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000237705.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000237737.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000237738.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000237751.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000237756.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000237773.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000237773.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000237819.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000237845.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000237877.2 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000237883.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000237886.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000237903.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000237945.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000237950.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000237976.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000237980.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000238045.5 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000238106.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000238122.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK Inhibitor VIII |
ENSG00000238140.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000238160.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000238184.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000238221.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000238221.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000238261.5 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000238273.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000238279.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000238279.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000238280.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000238290.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000239002.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000239213.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000239213.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK Inhibitor VIII |
ENSG00000239300.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000239300.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000239377.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000239407.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000239462.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000239480.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000239523.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000239523.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000239569.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000239608.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000239911.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000240005.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000240050.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000240057.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000240063.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000240063.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000240175.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000240254.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000240288.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000240288.3 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000240288.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000240373.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000240449.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000240476.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK Inhibitor VIII |
ENSG00000240498.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000240499.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000240541.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000240567.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000240571.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000240758.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000240758.2 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000240766.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000240859.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000240990.5 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000240990.5 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000240996.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000241014.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000241014.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000241158.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000241169.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000241211.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000241269.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000241313.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000241481.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000241490.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000241990.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000241990.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000241990.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000242258.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000242288.6 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000242349.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000242375.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000242391.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000242396.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000242474.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000242622.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000242759.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000242770.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000242795.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000242861.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000243176.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000243224.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000243230.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000243243.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000243479.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000243701.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000243795.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000243797.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000243819.3 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000243926.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000243960.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000244055.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000244063.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000244124.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000244184.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000244265.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000244265.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000244268.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000244393.3 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000244479.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000244558.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000244625.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000244649.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000244733.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000244733.4 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000244879.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK Inhibitor VIII |
ENSG00000244945.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000244945.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000245148.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000245248.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000245281.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000245322.2 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000245466.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000245468.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000245556.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000245614.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000245694.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000245711.2 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000245768.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000245904.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000245910.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000245937.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000246145.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000246174.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000246174.3 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000246225.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000246225.2 |
Predicted lncRNA |
Sarcoma |
|
| JNK Inhibitor VIII |
ENSG00000246228.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000246250.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000246263.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000246308.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK Inhibitor VIII |
ENSG00000246323.2 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000246523.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK Inhibitor VIII |
ENSG00000246526.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000246528.3 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000246548.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000246582.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000246582.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000246640.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000246662.2 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000246792.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000246792.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000246876.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000246889.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000246898.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000246982.2 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000246985.3 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000247092.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000247134.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000247199.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000247271.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000247271.2 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000247400.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000247498.5 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000247498.5 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000247556.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000247595.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000247595.2 |
Predicted lncRNA |
Sarcoma |
|
| JNK Inhibitor VIII |
ENSG00000247624.2 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000247679.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000247708.3 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000247708.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000247735.2 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000247796.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000247796.2 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000247809.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000247970.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK Inhibitor VIII |
ENSG00000247982.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000248008.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000248008.2 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000248019.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000248027.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000248092.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000248092.3 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000248125.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000248175.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000248175.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000248223.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000248243.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000248268.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000248275.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000248399.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000248399.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000248445.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000248468.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000248476.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000248544.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000248559.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000248597.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000248677.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000248714.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000248740.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000248740.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000248774.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000248787.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000248846.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000248925.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000248927.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000248964.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK Inhibitor VIII |
ENSG00000248996.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000249216.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000249328.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000249348.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000249430.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000249430.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000249451.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000249456.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000249476.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000249484.4 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000249492.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000249593.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000249684.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000249699.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000249731.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000249740.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000249825.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000249846.2 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000249859.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000249870.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000249894.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000249898.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000249942.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000250012.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000250056.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000250057.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000250069.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000250116.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000250116.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000250132.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000250132.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000250133.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000250133.2 |
Predicted lncRNA |
Sarcoma |
|
| JNK Inhibitor VIII |
ENSG00000250167.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000250220.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000250220.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000250260.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000250286.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000250303.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000250365.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000250397.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000250397.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000250451.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000250699.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000250714.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000250742.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000250802.2 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000250802.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000250903.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000250909.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000250920.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000250938.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000250988.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000250999.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000250999.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000251002.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000251018.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000251034.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000251059.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000251136.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000251136.4 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000251141.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000251143.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000251161.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000251161.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000251168.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000251298.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000251307.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK Inhibitor VIII |
ENSG00000251314.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000251330.3 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000251359.3 |
Predicted lncRNA |
Sarcoma |
|
| JNK Inhibitor VIII |
ENSG00000251381.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000251414.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000251442.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000251497.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK Inhibitor VIII |
ENSG00000251611.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000251615.3 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000251623.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000251661.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000251675.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000251676.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000251687.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000253138.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000253172.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000253187.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000253210.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000253284.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000253298.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000253307.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000253307.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000253335.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000253390.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000253392.2 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000253395.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000253399.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK Inhibitor VIII |
ENSG00000253399.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000253404.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000253430.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000253508.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000253526.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000253559.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000253582.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000253632.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000253632.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000253715.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000253716.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000253738.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000253741.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000253741.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000253741.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000253741.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000253754.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000253754.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000253768.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000253768.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000253773.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK Inhibitor VIII |
ENSG00000253773.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK Inhibitor VIII |
ENSG00000253825.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000253848.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000253854.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000253859.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000253878.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000253878.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000253893.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000253893.2 |
Predicted lncRNA |
Sarcoma |
|
| JNK Inhibitor VIII |
ENSG00000253917.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000253921.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000253930.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000253944.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000253948.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000253955.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000253978.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK Inhibitor VIII |
ENSG00000253982.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000254027.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000254027.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000254028.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000254031.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000254057.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000254081.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000254109.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000254144.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000254153.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000254180.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000254204.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000254263.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000254286.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000254286.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000254315.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK Inhibitor VIII |
ENSG00000254317.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000254340.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000254341.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000254414.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK Inhibitor VIII |
ENSG00000254432.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000254432.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000254459.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000254459.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000254473.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000254480.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000254485.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000254560.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000254602.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000254602.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000254606.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000254615.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000254662.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000254669.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000254682.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000254691.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000254756.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000254756.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000254757.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000254791.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000254826.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000254837.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000254872.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000254973.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000254973.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000254985.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000254985.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000254988.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000255050.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000255052.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK Inhibitor VIII |
ENSG00000255100.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000255121.2 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000255124.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000255135.3 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000255153.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000255164.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000255176.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000255198.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000255198.3 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000255202.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000255234.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000255240.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000255240.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK Inhibitor VIII |
ENSG00000255308.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000255318.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000255320.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000255320.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000255328.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000255343.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000255375.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000255409.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000255434.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000255449.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000255495.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000255517.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000255539.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000255621.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK Inhibitor VIII |
ENSG00000255669.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000255670.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK Inhibitor VIII |
ENSG00000255741.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000255741.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000255746.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000255867.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK Inhibitor VIII |
ENSG00000255867.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000255867.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000255893.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000255966.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000255989.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000255989.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000255989.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK Inhibitor VIII |
ENSG00000255992.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000256092.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000256139.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000256146.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000256268.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000256278.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000256312.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000256360.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000256417.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000256433.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000256458.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000256564.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000256603.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000256686.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000256690.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000256746.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000256789.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK Inhibitor VIII |
ENSG00000256940.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000256955.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000256967.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000257084.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000257086.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000257135.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000257139.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK Inhibitor VIII |
ENSG00000257151.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000257222.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000257261.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000257261.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000257261.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK Inhibitor VIII |
ENSG00000257264.2 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000257270.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000257303.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000257337.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK Inhibitor VIII |
ENSG00000257337.2 |
Predicted lncRNA |
Sarcoma |
|
| JNK Inhibitor VIII |
ENSG00000257354.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000257410.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000257433.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000257443.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000257452.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000257475.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000257509.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000257515.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000257556.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000257605.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000257621.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000257647.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000257647.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000257696.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000257698.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000257742.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000257742.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000257808.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000257809.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK Inhibitor VIII |
ENSG00000257815.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000257824.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000257829.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000257894.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000257913.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000257953.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000258001.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000258017.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK Inhibitor VIII |
ENSG00000258035.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000258044.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000258057.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000258057.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000258057.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000258096.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK Inhibitor VIII |
ENSG00000258099.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000258114.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000258199.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000258274.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000258285.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000258301.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000258317.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000258323.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000258344.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000258378.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000258407.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK Inhibitor VIII |
ENSG00000258410.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000258413.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000258424.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000258428.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000258457.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000258479.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000258537.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000258548.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000258558.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000258604.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000258620.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000258620.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000258661.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000258667.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000258682.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000258701.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000258731.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000258809.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000258825.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000258857.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000258912.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000258935.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000258938.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000258943.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000258946.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000258957.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000258959.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000258976.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000258982.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000259031.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000259062.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000259062.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000259081.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000259083.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000259088.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000259088.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000259093.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000259115.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000259118.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK Inhibitor VIII |
ENSG00000259129.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000259146.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000259187.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK Inhibitor VIII |
ENSG00000259201.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000259218.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000259222.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000259240.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000259290.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000259345.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000259365.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK Inhibitor VIII |
ENSG00000259366.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000259366.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000259402.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK Inhibitor VIII |
ENSG00000259402.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000259408.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000259417.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK Inhibitor VIII |
ENSG00000259422.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000259424.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000259424.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000259448.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000259474.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000259553.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000259553.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000259590.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000259617.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK Inhibitor VIII |
ENSG00000259623.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000259623.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000259628.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK Inhibitor VIII |
ENSG00000259654.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000259687.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000259709.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000259712.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000259715.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK Inhibitor VIII |
ENSG00000259725.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000259727.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000259727.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000259736.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000259744.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000259756.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000259758.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000259771.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000259772.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000259774.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000259783.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000259802.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000259806.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000259814.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000259820.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000259820.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000259826.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000259886.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000259943.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000259953.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000259953.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000259994.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000260006.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000260011.2 |
Predicted lncRNA |
Sarcoma |
|
| JNK Inhibitor VIII |
ENSG00000260022.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000260022.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000260034.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000260046.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000260060.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000260065.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK Inhibitor VIII |
ENSG00000260065.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000260077.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK Inhibitor VIII |
ENSG00000260083.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000260095.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000260136.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000260136.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000260145.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000260179.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK Inhibitor VIII |
ENSG00000260193.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000260193.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK Inhibitor VIII |
ENSG00000260219.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000260219.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000260233.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000260236.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000260257.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000260265.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000260273.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000260277.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000260278.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000260306.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK Inhibitor VIII |
ENSG00000260329.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000260331.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000260336.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000260349.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000260351.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK Inhibitor VIII |
ENSG00000260351.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000260352.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000260361.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000260367.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000260369.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000260396.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000260400.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000260404.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000260411.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000260418.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000260423.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000260441.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000260441.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000260466.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK Inhibitor VIII |
ENSG00000260475.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000260493.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000260495.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK Inhibitor VIII |
ENSG00000260515.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000260517.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000260517.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000260528.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000260583.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000260619.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000260625.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000260630.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000260647.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000260655.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000260664.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000260672.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000260735.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000260744.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000260751.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000260751.2 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000260766.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK Inhibitor VIII |
ENSG00000260766.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000260766.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000260774.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000260777.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000260778.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000260790.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000260792.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK Inhibitor VIII |
ENSG00000260793.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000260793.2 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000260793.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000260796.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK Inhibitor VIII |
ENSG00000260803.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000260804.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000260816.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000260831.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000260871.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000260877.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000260911.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000260917.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000260917.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000260919.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000260927.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000260931.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000260936.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000260936.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK Inhibitor VIII |
ENSG00000260953.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000260954.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000260992.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000261002.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000261005.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000261005.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000261008.2 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000261015.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000261019.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000261024.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000261024.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000261029.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000261043.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000261051.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000261101.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000261118.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000261141.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000261159.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000261173.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000261183.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000261183.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000261188.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000261189.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000261189.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000261195.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000261204.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000261207.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000261226.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000261250.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000261251.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000261254.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000261270.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000261286.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000261288.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000261302.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000261324.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000261334.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK Inhibitor VIII |
ENSG00000261337.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000261338.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000261342.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000261342.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000261353.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000261355.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000261360.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000261366.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000261372.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000261396.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000261407.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000261407.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000261420.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000261420.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000261428.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000261437.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000261441.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000261442.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000261455.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000261455.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000261468.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000261469.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000261488.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000261490.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000261505.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000261512.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000261513.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000261526.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000261529.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000261534.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000261550.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000261572.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000261572.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000261574.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000261582.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK Inhibitor VIII |
ENSG00000261596.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000261596.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000261613.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000261613.2 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000261617.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000261633.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000261662.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000261662.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000261693.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000261712.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000261723.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000261731.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000261737.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000261766.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000261804.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000261837.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000261864.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK Inhibitor VIII |
ENSG00000261879.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000261879.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK Inhibitor VIII |
ENSG00000261924.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000261924.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000261971.2 |
Predicted lncRNA |
Sarcoma |
|
| JNK Inhibitor VIII |
ENSG00000261978.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000262001.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000262020.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000262089.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000262094.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000262098.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000262147.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000262152.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000262171.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000262185.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000262185.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK Inhibitor VIII |
ENSG00000262188.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK Inhibitor VIII |
ENSG00000262194.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000262202.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000262228.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000262265.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000262265.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000262298.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000262372.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000262412.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000262434.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000262434.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000262477.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000262477.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000262482.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000262652.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000262678.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000262692.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000262714.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000262745.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000262766.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000262768.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000262777.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000262777.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000262810.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000262823.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000262823.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000262877.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000262898.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000262905.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000262951.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000262979.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000263011.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000263011.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000263033.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000263033.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000263050.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000263072.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000263080.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000263105.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000263244.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000263280.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000263293.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000263300.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000263338.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000263345.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000263412.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000263466.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000263499.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000263531.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000263683.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000263753.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000263859.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000263860.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000263884.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000264007.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000264188.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000264196.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000264247.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000264272.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000264448.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000264575.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000264575.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000264577.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000264608.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000264608.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000264635.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000264769.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000264885.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000264920.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000264937.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000264940.2 |
Predicted lncRNA |
Sarcoma |
|
| JNK Inhibitor VIII |
ENSG00000264940.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000264964.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000265091.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000265206.2 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000265222.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK Inhibitor VIII |
ENSG00000265349.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000265399.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000265479.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000265490.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK Inhibitor VIII |
ENSG00000265490.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000265656.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000265666.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000265688.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000265688.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000265743.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK Inhibitor VIII |
ENSG00000265749.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000265750.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000265778.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000265801.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK Inhibitor VIII |
ENSG00000265992.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000266010.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000266053.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000266176.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000266237.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000266441.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000266456.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000266469.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000266473.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK Inhibitor VIII |
ENSG00000266538.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000266598.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000266601.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000266644.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000266651.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000266709.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK Inhibitor VIII |
ENSG00000266718.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000266729.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000266783.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000266783.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000266821.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000266824.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000266835.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000266850.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000266877.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000266895.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK Inhibitor VIII |
ENSG00000266904.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000266911.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK Inhibitor VIII |
ENSG00000266942.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000266947.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000266969.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000266976.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000266994.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK Inhibitor VIII |
ENSG00000266999.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000267003.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000267009.2 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000267016.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000267016.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000267016.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000267034.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000267040.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000267052.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000267064.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000267065.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000267067.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000267073.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000267080.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000267080.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000267082.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000267096.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000267108.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000267117.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000267117.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK Inhibitor VIII |
ENSG00000267118.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000267150.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000267150.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000267151.2 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000267151.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000267161.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000267161.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000267167.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000267196.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000267197.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000267199.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK Inhibitor VIII |
ENSG00000267221.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK Inhibitor VIII |
ENSG00000267230.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000267232.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000267244.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000267249.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000267251.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000267251.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000267262.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK Inhibitor VIII |
ENSG00000267263.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000267272.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000267277.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000267278.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000267282.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000267302.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000267321.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000267321.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000267321.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000267327.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000267342.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000267347.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000267348.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000267348.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000267374.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK Inhibitor VIII |
ENSG00000267375.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000267394.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000267395.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000267419.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000267424.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000267449.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000267476.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000267481.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000267543.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000267546.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000267546.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000267567.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000267568.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000267575.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000267582.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000267651.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000267701.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000267705.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000267730.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000267734.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000267737.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000267747.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000267749.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000267751.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK Inhibitor VIII |
ENSG00000267758.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK Inhibitor VIII |
ENSG00000267759.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000267767.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000267785.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000267786.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000267787.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000267858.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000267904.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000267927.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000267934.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000267940.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000267940.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000268001.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000268015.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000268047.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000268049.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000268049.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000268061.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000268061.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000268066.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000268081.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000268087.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000268199.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000268205.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000268262.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK Inhibitor VIII |
ENSG00000268316.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK Inhibitor VIII |
ENSG00000268362.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000268458.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000268471.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000268530.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000268543.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000268573.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000268573.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000268584.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000268670.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000268670.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000268683.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000268889.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK Inhibitor VIII |
ENSG00000268913.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000268913.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000268945.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000269019.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000269038.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000269038.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000269044.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000269086.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000269102.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000269161.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000269161.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000269191.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000269191.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK Inhibitor VIII |
ENSG00000269220.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000269293.2 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000269365.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000269386.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000269386.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000269387.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000269423.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000269427.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000269427.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000269439.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000269444.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000269487.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000269534.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000269574.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000269600.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000269609.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000269609.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000269680.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000269688.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000269696.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000269843.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000269843.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000269867.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000269887.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000269888.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000269893.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000269894.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000269895.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000269896.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000269896.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK Inhibitor VIII |
ENSG00000269901.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000269923.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000269924.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000269947.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000269947.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000269949.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000269956.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000269958.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000269966.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000269973.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000269979.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000269980.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK Inhibitor VIII |
ENSG00000269996.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000270009.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000270010.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK Inhibitor VIII |
ENSG00000270018.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000270019.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000270020.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK Inhibitor VIII |
ENSG00000270022.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000270022.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000270028.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000270030.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000270049.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000270050.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000270066.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000270068.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000270069.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000270081.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000270081.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000270084.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000270100.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000270102.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000270103.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000270104.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000270109.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000270124.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000270130.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000270143.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000270165.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000270170.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000270178.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000270190.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000270195.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000270223.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000270344.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000270362.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000270426.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000270562.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000270604.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000270604.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000270605.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK Inhibitor VIII |
ENSG00000270641.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000270641.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000270726.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000270751.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000270760.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000270760.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000270828.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000270866.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000270933.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000270949.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000270949.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000270951.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000270964.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000270964.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000271009.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000271020.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000271119.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK Inhibitor VIII |
ENSG00000271119.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000271119.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK Inhibitor VIII |
ENSG00000271147.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000271218.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000271228.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK Inhibitor VIII |
ENSG00000271265.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000271270.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000271359.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000271366.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000271382.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000271382.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK Inhibitor VIII |
ENSG00000271398.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK Inhibitor VIII |
ENSG00000271555.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK Inhibitor VIII |
ENSG00000271576.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000271643.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000271646.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000271659.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000271659.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000271732.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000271737.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000271738.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000271755.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000271757.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000271781.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000271782.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000271789.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000271816.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000271820.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK Inhibitor VIII |
ENSG00000271843.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000271845.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000271851.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000271851.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000271855.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000271855.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000271856.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000271862.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000271882.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000271888.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000271912.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000271912.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000271927.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000271947.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000271948.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000271948.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000271948.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000271948.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000271964.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000271964.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000271966.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000271975.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000271978.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000271983.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000271993.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000271993.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000271998.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000272003.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000272004.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK Inhibitor VIII |
ENSG00000272005.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000272005.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000272009.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000272010.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000272023.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK Inhibitor VIII |
ENSG00000272033.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000272048.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000272068.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000272071.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000272072.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000272076.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000272077.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000272079.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000272091.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000272092.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000272097.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000272102.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000272103.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000272109.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000272123.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK Inhibitor VIII |
ENSG00000272138.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000272140.2 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000272141.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000272146.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000272156.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000272156.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000272158.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000272161.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000272168.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000272181.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000272198.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000272205.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000272205.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000272205.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000272211.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000272216.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000272219.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000272221.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000272225.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000272248.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000272254.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000272275.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000272298.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000272335.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000272338.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000272346.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000272346.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000272373.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000272374.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000272402.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000272416.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK Inhibitor VIII |
ENSG00000272420.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000272447.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000272452.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000272452.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000272463.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000272472.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000272472.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK Inhibitor VIII |
ENSG00000272518.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000272518.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000272520.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000272520.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000272525.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000272529.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000272529.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000272562.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000272564.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000272588.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000272609.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000272620.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000272627.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000272627.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000272631.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000272645.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000272663.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000272669.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000272669.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000272682.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000272688.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000272690.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000272695.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000272695.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000272696.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000272699.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000272707.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000272734.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000272735.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000272777.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000272782.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000272791.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000272799.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000272828.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000272829.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000272836.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000272836.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000272848.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000272849.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000272849.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK Inhibitor VIII |
ENSG00000272858.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000272862.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000272870.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000272870.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000272871.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000272888.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000272911.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000272914.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000272933.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000272949.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000272983.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000272989.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000272992.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000272995.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000273002.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000273004.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000273008.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000273014.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK Inhibitor VIII |
ENSG00000273014.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000273015.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK Inhibitor VIII |
ENSG00000273015.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000273015.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000273027.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000273038.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000273066.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000273081.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000273081.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000273096.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000273102.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000273113.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000273116.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK Inhibitor VIII |
ENSG00000273116.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000273131.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000273145.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000273148.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000273164.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000273174.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000273175.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000273176.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000273183.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000273190.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000273203.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000273209.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000273216.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000273233.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000273237.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000273243.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000273247.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000273249.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK Inhibitor VIII |
ENSG00000273281.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000273284.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000273290.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000273290.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000273306.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000273306.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000273313.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| JNK Inhibitor VIII |
ENSG00000273319.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000273335.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000273338.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000273344.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000273350.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000273352.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000273424.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000273424.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000273432.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000273437.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000273449.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| JNK Inhibitor VIII |
ENSG00000273454.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK Inhibitor VIII |
ENSG00000273472.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK Inhibitor VIII |
ENSG00000273473.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000273474.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK Inhibitor VIII |
ENSG00000273476.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|